Matoba Tetsuya, Sakamoto Kazuo, Nakai Michikazu, Ichimura Kenzo, Mohri Masahiro, Tsujita Yasuyuki, Yamasaki Masao, Ueki Yasushi, Tanaka Nobuhiro, Hokama Yohei, Fukutomi Motoki, Hashiba Katsutaka, Fukuhara Rei, Suwa Satoru, Matsuura Hirohide, Hosoda Hayato, Nakashima Takahiro, Tahara Yoshio, Sumita Yoko, Nishimura Kunihiro, Miyamoto Yoshihiro, Yonemoto Naohiro, Yagi Tsukasa, Tachibana Eizo, Nagao Ken, Ikeda Takanori, Sato Naoki, Tsutsui Hiroyuki
Department of Cardiovascular Medicine, Kyushu University.
JCS Shock Registry Scientific Committee.
Circ J. 2021 Sep 24;85(10):1797-1805. doi: 10.1253/circj.CJ-20-0655. Epub 2021 Mar 4.
The high mortality of acute myocardial infarction (AMI) with cardiogenic shock (i.e., Killip class IV AMI) remains a challenge in emergency cardiovascular care. This study aimed to examine institutional factors, including the number of JCS board-certified members, that are independently associated with the prognosis of Killip class IV AMI patients.
In the Japanese registry of all cardiac and vascular diseases-diagnosis procedure combination (JROAD-DPC) database (years 2012-2016), the 30-day mortality of Killip class IV AMI patients (n=21,823) was 42.3%. Multivariate analysis identified age, female sex, admission by ambulance, deep coma, and cardiac arrest as patient factors that were independently associated with higher 30-day mortality, and the numbers of JCS board-certified members and of intra-aortic balloon pumping (IABP) cases per year as institutional factors that were independently associated with lower mortality in Killip class IV patients, although IABP was associated with higher mortality in Killip classes I-III patients. Among hospitals with the highest quartile (≥9 JCS board-certified members), the 30-day mortality of Killip class IV patients was 37.4%.
A higher numbers of JCS board-certified members was associated with better survival of Killip class IV AMI patients. This finding may provide a clue to optimizing local emergency medical services for better management of AMI patients in Japan.
急性心肌梗死(AMI)合并心源性休克(即Killip IV级AMI)的高死亡率仍是急诊心血管护理中的一项挑战。本研究旨在探讨包括日本循环系统学会(JCS)认证会员数量在内的机构因素,这些因素与Killip IV级AMI患者的预后独立相关。
在日本所有心脏和血管疾病诊断程序组合登记处(JROAD-DPC)数据库(2012 - 2016年)中,Killip IV级AMI患者(n = 21,823)的30天死亡率为42.3%。多变量分析确定年龄、女性、救护车送医、深度昏迷和心脏骤停为与30天更高死亡率独立相关的患者因素,而JCS认证会员数量和每年主动脉内球囊反搏(IABP)病例数为与Killip IV级患者较低死亡率独立相关的机构因素,尽管IABP与Killip I - III级患者的更高死亡率相关。在四分位数最高(≥9名JCS认证会员)的医院中,Killip IV级患者的30天死亡率为37.4%。
JCS认证会员数量较多与Killip IV级AMI患者更好的生存率相关。这一发现可能为优化日本当地急诊医疗服务以更好地管理AMI患者提供线索。